One of the most frequently asked questions about Selank is whether there is an ideal time of day to take it. Currently, scientific literature does not indicate a universally recommended dosing schedule. Most research has focused on Selank's effects on anxiety, stress resistance, cognitive function, neurochemistry, and brain activity, rather than on determining the optimal time of administration [1–4].
As a result, researchers did not identify a specific morning, afternoon, or evening pattern that consistently provided better results. The most appropriate time of administration may depend on the research objective, such as supporting cognitive function, regulating emotions, or managing stress. Individuals seeking information on the phrase „when to take Selank” should remember that current scientific data does not indicate one best time of day.
What Time of Day Should Selank Be Used?
Current research suggests that the timing of Selank administration depends mainly on the intended purpose, rather than on a biologically confirmed need for administration at a specific time.
Research indicates that Selank affects several neurobiological systems, including GABAergic signaling, enkephalin metabolism, neurotrophic factors such as BDNF (brain-derived neurotrophic factor), and pathways related to the immune system [2–5]. However, currently available data do not show these mechanisms to be strongly linked to a specific time of day.
Unlike some peptides related to growth hormone secretion or sleep physiology, Selank has been primarily studied for its anxiolytic, neuroprotective, and neuroregulatory effects. For this reason, published studies do not provide strong evidence that using it in the morning is better than in the evening or vice versa.
Can Selank be used in the evening?
Current scientific literature does not suggest that taking Selank in the evening is problematic. On the contrary, some researchers point out that its effects on stress regulation and emotional balance may support a calmer mental state in the evening hours [2,4].
Importantly, Selank does not act like a classic stimulant. Clinical trials conducted in individuals with generalized anxiety disorder showed a reduction in anxiety symptoms without excessive arousal, nervousness, or overstimulation [1]. Animal studies have also demonstrated anxiolytic effects without the marked sedation characteristic of benzodiazepines [6].
Since Selank appears to support balance within several neurotransmitter systems, available data do not indicate that evening use would be inappropriate.
Selank Before Sleep
Although there are few studies directly investigating the impact of Selank on sleep, current data do not indicate that it negatively affects normal sleep physiology. Some proposed mechanisms of action, such as stress reduction and emotional regulation, may theoretically support relaxation before sleep [2,4].
It is worth emphasizing, however, that Selank was not developed as a sleep aid peptide. Most research focuses on anxiety, cognitive function, neuroprotection, and neurochemical regulation, rather than insomnia or sleep disorders [1–5].
For this reason, there is currently insufficient evidence to recommend the use of Selank solely for the purpose of improving sleep quality.
Does Selank require refrigeration?
How to Store Selank?
Proper storage is essential for maintaining peptide stability. Like many other peptide compounds, Selank can degrade due to high temperature, light, moisture, and significant temperature fluctuations.
Most scientific research on Selank focuses on its biological activity, not storage conditions. Consequently, scientific literature does not define a single universal storage standard suitable for all formulations [1–5].
Storage requirements can depend on several factors:
- Is the peptide in lyophilized powder form or a ready-to-use solution.
- Applied formulation and excipients.
- Producer or research supplier.
- Planned storage period.
For this reason, researchers usually follow product-specific instructions.
Should Selank be stored in the refrigerator?
Scientific literature does not present a single universal recommendation for storing all products containing Selank. However, in peptide research, refrigeration is a common practice, as lower temperatures help slow down the degradation process and support product stability.
Lyophilized peptides and reconstituted peptide solutions often exhibit different stabilities, so storage recommendations may vary depending on the product form.
Since there are no standardized storage protocols in the literature, the manufacturer's guidelines remain the most reliable source of information.
Does nasal spray with Selank require refrigeration?
Studies confirm that Selank retains biological activity after intranasal administration; however, available publications do not specify standardized storage conditions for nasal spray preparations [3,4].
Nasal preparations often contain additional ingredients, such as buffers, stabilizers, preservatives, and solvents. These can significantly affect the product's stability and storage requirements.
Because formulations vary, recommendations for storing sprays should be based on the manufacturer's instructions for the specific product.
Storage of Reconstituted Selank
The available literature does not contain controlled stability studies assessing the durability of reconstituted Selank solutions.
After dissolving the peptide in a liquid, factors such as risk of contamination, oxidation, hydrolysis, and temperature sensitivity become more significant. For this reason, ready-made solutions often require more stringent storage conditions than the dry powder.
Since there is currently no universally accepted stability data, follow the manufacturer's recommendations for the specific formulation.
What is the half-life of Selank?
Is the half-life of Selank known?
One of the most frequently asked questions regarding Selank is its half-life. Despite a large number of studies on the biological activity of this peptide, no pharmacokinetic studies in humans have been published to date that definitively determine its plasma half-life, blood concentration profile, or exact elimination time [2–5].
Most research has focused on effects such as anxiety reduction, neuroprotection, neurotransmitter regulation, BDNF expression, and influence on gene expression, rather than pharmacokinetic measurements.
Why is it difficult to determine the half-life of selank?
Selank is a synthetic heptapeptide with the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed to have greater stability than its natural precursor, tuftsin, due to the addition of the Pro-Gly-Pro fragment [5].
Although this modification increases resistance to enzymatic degradation, it does not automatically determine the peptide's circulation half-life. Accurately determining the half-life requires specialized pharmacokinetic studies monitoring blood concentration over time, and such studies are currently lacking.
How Long Does Selank Stay in the Body?
Without formal pharmacokinetic data, it is not possible to accurately determine how long Selank remains detectable in the body.
It is also important to distinguish the physical presence of the peptide from the duration of its biological effects. Studies suggest that Selank may initiate processes related to GABA receptor modulation, enkephalin metabolism, BDNF regulation, and gene expression, which may persist even after the peptide itself has been metabolized [2-5].
As a result, the duration of biological action may be longer than the peptide's circulation period.
How long does Selank last?
Although the exact half-life remains unknown, several studies suggest that Selank may induce measurable biological effects beyond the direct administration period.
Animal studies have shown a sustained reduction in anxiety-related behaviors during multi-week administration [6]. Other works have documented long-lasting changes in neurotransmitter systems, gene expression, and neurotrophic pathways following intranasal administration of Selank [2–4].
These results suggest that the biological effects of Selank may persist longer than the peptide itself remains present in the bloodstream, although the exact duration has not yet been determined.
Summary
Current scientific data do not indicate a single optimal time of day for Selank administration. Studies suggest that the choice of administration time depends more on the intended purpose than on a specific biological requirement. Morning, afternoon, and evening use have all been discussed, but no regimen has shown a clear advantage.
Similarly, although Selank was designed to be more stable than tuftsine, its exact half-life and elimination time remain unknown due to a lack of dedicated pharmacokinetic studies. However, it is known to affect multiple neurobiological systems and can produce effects that last longer than the peptide's presence in circulation.
Disclaimer
This material is for educational and informational purposes only. Selank remains a research peptide in many countries, and many aspects concerning its pharmacokinetics, storage stability, and optimal administration timing have yet to be fully characterized in large human clinical trials.
For research purposes only: Selank products offered by Semax Polska are intended solely for laboratory and scientific research. They are not approved for human consumption, medical use, diagnosis, treatment, or disease prevention. All research materials should be used in accordance with applicable regulations and the principles of good laboratory practice.
References
[1] Zozulia, A. A., Neznamov, G. G., Siuniakov, T. S., Kost, N. V., Gabaeva, M. V., Sokolov, O. Y., Serebriakova, E. V., Siranchieva, O. A., Andriushenko, A. V., Telesheva, E. S., Siuniakov, S. A., Smulevich, A. B., Myasoedov, N. F., & Seredenin, S. B. (2008). Efficacy and Possible Mechanisms of Action of a New Peptide Anxiolytic Selank in the Therapy of Generalized Anxiety Disorders and Neurasthenia. Journal of Neurology and Psychiatry named after S.S. Korsakov, 108(4), 38–48. https://pubmed.ncbi.nlm.nih.gov/18454096/
[2] Vyunova, T. V., Andreeva, L., Shevchenko, K., & Myasoedov, N. F. (2018). Peptide-Based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein and Peptide Letters, 25(10), 914–923. https://doi.org/10.2174/0929866525666180925144642
[3] Levitskaya, N. G., Andreeva, L. A., Mezentseva, M. V., Shapoval, I. M., Podchernyaeva, R. Y., Shcherbenko, V. E., Potapova, L. A., Russu, L. I., Ershov, F. I., & Myasoedov, N. F. (2010). Intranasal Administration of the Peptide Selank Regulates BDNF Expression in Rat Hippocampus In Vivo. Doklady Biological Sciences, 431, 79–82.
[4] Andreeva, L. A., Nagaev, I. Y., Mezentseva, M. V., Shapoval, I. M., Podchernyaeva, R. Y., Shcherbenko, V. E., Potapova, L. A., Russu, L. I., Ershov, F. I., & Myasoedov, N. F. (2010). Antiviral Properties of Structural Fragments of the Peptide Selank. Doklady Biological Sciences, 431, 79–82. https://doi.org/10.1134/S0012496610020031
[5] PubChem. (2026). Selank (CID 11765600). National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/11765600
[6] Czabak-Garbacz, R., Cygan, B., Wolański, Ł., & Kozlovsky, I. (2006). Influence of Long-Term Treatment with Tuftsin Analogue TP-7 on Anxiety-Phobic States and Body Weight. Pharmacological Reports, 58(4), 562–567. PMID: 16963804.